Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ISRCTN13981390) titled 'Evaluation of the use of dried blood samples for the detection of the 4-doping product vadadustat (Vafseo(R))' on June 12.
Study Type: Interventional
Study Design:
Allocation: N/A: single arm study
Masking: Open (masking not used)
Control: Uncontrolled
Assignment: Single
Purpose: This study aims to assess the capacity of dried blood spots (cards and Tasso-m20 devices) to detect vadadustat after oral administration.
Primary Sponsor: University Hospital of Lausanne
Condition:
The detection of vadadustat in dried blood spots (DBS) after a single oral administration.
Other
Intervention:
Single oral administrati...